直接面向消费者的基因测试市场 - 全球产业规模、份额、趋势、机会和预测，按测试类型、技术、样本、配销通路、地区和竞争细分，2019-2029F

2023 年，全球直接面向消费者(DTC) 基因测试市场估值为15 亿美元，预计在预测期内将出现令人印象深刻的成长，到2029 年复合年增长率为8.45%。 (DTC) 基因测试市场是一个充满活力且快速发展的领域，处于医疗保健和消费者基因组学的交叉点。 DTC 基因检测涉及个人直接获取有关自己的遗传讯息，而无需医疗保健专业人员的参与。

DTC 基因检测市场的核心是为那些对自己的基因组成及其对健康、血统和性状的影响感到好奇的个人提供便利。消费者可以在线上订购检测试剂盒，在家中接收，提供 DNA 样本（通常透过唾液），然后将样本交回给检测公司。然后该公司分析 DNA，产生有关个人遗传讯息各个方面的报告。市场的主要驱动力之一是人们对了解健康状况遗传倾向的兴趣日益浓厚。 DTC 基因检测公司可深入了解个人罹患某些类型癌症、心血管疾病和遗传性疾病等疾病的遗传风险。这些资讯使消费者能够就他们的生活方式、医疗保健和预防措施做出明智的决定。血统测试已成为一项流行的功能，允许个人探索他们的遗传遗产并发现有关其家族史的资讯。基因组学的技术进步，特别是 DNA 定序和资料分析的技术进步，在 DTC 基因检测市场的扩张中进一步发挥了至关重要的作用。基因检测结果准确性和深度的提高有助于提高市场的可信度和吸引力。

该市场的特点是参与者多元化，包括成熟公司、新创公司和知名消费者基因组品牌。这些公司通常透过提供独特的功能（例如特定的健康风险评估、详细的血统报告或特征分析）来使自己脱颖而出。与研究机构和製药公司的资料共享和合作研究合作有助于市场的活力。

DTC 基因检测市场也面临挑战和伦理考量。与基因资料处理相关的隐私问题、敏感资讯的潜在滥用以及测试结果的准确性都是受到审查的主题。 DTC 模式中缺乏遗传咨询，引发如何向消费者适当解释和传达复杂遗传讯息的问题。

主要市场驱动因素

消费者对个人化健康见解的需求

主要市场挑战

隐私和安全问题

结果的准确性和解释

监管和道德考虑

遗传咨询和知情同意

主要市场趋势

扩展的测试产品和服务

远距医疗和远距咨询

细分市场洞察

测试类型见解

技术洞察

区域洞察

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：全球直接面向消费者 (DTC) 基因检测市场展望

• 市场规模预测
  • 按价值
• 市占率预测
  • 依测试类型（祖先关係测试、预测测试、营养基因组测试、携带者测试、护肤测试等）
  • 依技术（单核苷酸多态性（SP）晶片、标靶分析、全基因组定序（WGS）、其他）
  • 依样本（唾液、尿液、血液、其他）
  • 依配销通路（线上、线下）
  • 按地区
  • 按公司划分 (2023)
• 市场地图

第 5 章：亚太地区直接面向消费者 (DTC) 基因检测市场展望

• 市场规模预测
  • 按价值
• 市占率预测
  • 按测试类型
  • 依技术
  • 按样品
  • 按配销通路
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 澳洲
  • 日本
  • 韩国

第 6 章：欧洲直接面向消费者 (DTC) 基因检测市场展望

• 市场规模预测
  • 按价值
• 市占率预测
  • 按测试类型
  • 依技术
  • 按样品
  • 按配销通路
  • 按国家/地区
• 欧洲：国家分析
  • 法国
  • 德国
  • 西班牙
  • 义大利
  • 英国

第 7 章：北美直接面向消费者 (DTC) 基因检测市场展望

• 市场规模预测
  • 按价值
• 市占率预测
  • 按测试类型
  • 依技术
  • 按样品
  • 按配销通路
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第 8 章：南美洲直接面向消费者 (DTC) 基因检测市场展望

• 市场规模预测
  • 按价值
• 市占率预测
  • 按测试类型
  • 依技术
  • 按样品
  • 按配销通路
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 9 章：中东和非洲直接面向消费者 (DTC) 基因检测市场展望

• 市场规模预测
  • 按价值
• 市占率预测
  • 按测试类型
  • 依技术
  • 按样品
  • 按配销通路
  • 按国家/地区
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 10 章：市场动态

• 司机
• 挑战

第 11 章：市场趋势发展

• 最近的发展
• 产品发布
• 併购

第 12 章：全球直接面向消费者 (DTC) 基因检测市场：SWOT 分析

第 13 章：波特的五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第14章：竞争格局

• andMe, Inc
• Ancestry.com, LLC
• Color Health, Inc
• Helix, Inc.
• Counsyl, Inc.
• MyHeritage Ltd.
• Living DNA Ltd.
• Mapmygenome India Limited
• Full Genomes Corporation, Inc
• Direct Laboratory Services, LLC

第 15 章：策略建议

第 16 章：关于我们免责声明

Global Direct-To-Consumer (DTC) Genetic Testing Market wasvalued at USD 1.50 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.45% through 2029. The Direct-to-Consumer (DTC) Genetic Testing Market is a dynamic and rapidly evolving sector at the intersection of healthcare and consumer genomics. DTC genetic testing involves individuals directly accessing genetic information about themselves without the involvement of healthcare professionals.

At the core of the DTC Genetic Testing Market is the accessibility it offers to individuals who are curious about their genetic makeup and its implications for health, ancestry, and traits. Consumers can order testing kits online, receive them at home, provide a DNA sample (usually through saliva), and return the sample to the testing company. The company then analyzes the DNA to generate reports on various aspects of the individual's genetic information. One of the key drivers of the market is the rising interest in understanding one's genetic predispositions for health conditions. DTC genetic testing companies provide insights into an individual's genetic risk for conditions such as certain types of cancer, cardiovascular diseases, and hereditary conditions. This information empowers consumers to make informed decisions about their lifestyle, healthcare, and preventive measures. Ancestry testing has become a popular feature, allowing individuals to explore their genetic heritage and discover information about their family history. Technological advancements in genomics, particularly in DNA sequencing and data analysis, have further played a crucial role in the expansion of the DTC Genetic Testing Market. Improvements in the accuracy and depth of genetic testing results contribute to the market's credibility and appeal.

The market is characterized by a diverse range of players, including established companies, startups, and well-known consumer genomics brands. These companies often differentiate themselves by offering unique features such as specific health risk assessments, detailed ancestry reports, or traits analysis. Partnerships with research institutions and pharmaceutical companies for data sharing and collaborative studies contribute to the market's dynamism.

The DTC Genetic Testing Market also faces challenges and ethical considerations. Privacy concerns related to the handling of genetic data, the potential misuse of sensitive information, and the accuracy of test results are subjects of scrutiny. The lack of genetic counseling in the DTC model raises questions about the appropriate interpretation and communication of complex genetic information to consumers.

Key Market Drivers

Consumer Demand for Personalized Health Insights

Consumer demand for personalized health insights stands as the driving force behind the rapid growth and evolution of the Direct-to-Consumer (DTC) Genetic Testing Market. This demand reflects a paradigm shift in healthcare, where individuals are increasingly taking proactive steps to gain a deeper understanding of their genetic makeup and its implications for their well-being. At the core of this driver is the human desire for knowledge-specifically, knowledge about one's own genetic information and its potential impact on health. People are inherently curious about their predispositions to various health conditions, the likelihood of developing certain diseases, and insights into their overall genetic health profile. DTC genetic testing addresses this curiosity by providing individuals direct access to information encoded in their DNA without the need for intermediary healthcare professionals.

The appeal of personalized health insights lies in the empowerment it offers to consumers. Armed with knowledge about their genetic risk factors, individuals can make informed decisions about their lifestyle, health management, and preventive measures. For instance, if a person learns about a heightened genetic susceptibility to a specific condition, they may choose to adopt lifestyle changes, undergo more frequent screenings, or consult with healthcare professionals for targeted preventive strategies. The growing emphasis on preventive healthcare aligns with the demand for personalized genetic insights. Consumers recognize that understanding their genetic predispositions allows for early intervention and proactive measures to mitigate potential health risks. This shift toward a preventive healthcare mindset is reshaping the healthcare landscape, with individuals seeking to leverage genetic information to optimize their health and well-being.

The COVID-19 pandemic has further highlighted the importance of accessible and convenient healthcare services. With lockdowns and restrictions limiting physical interactions, consumers turned to DTC genetic testing as a viable option for gaining health insights from the safety of their homes. The pandemic accelerated the adoption of remote healthcare solutions, and DTC genetic testing emerged as a resilient and adaptable option for individuals seeking health information during challenging times.

Key Market Challenges

Privacy and Security Concerns

Privacy and security concerns pose significant challenges for the Direct-to-Consumer (DTC) Genetic Testing Market. The inherent sensitivity of genetic data raises fears about potential breaches, unauthorized access, and misuse. Consumers worry about the protection of their most personal information. Safeguarding genetic data against cyber threats and ensuring compliance with data protection regulations are paramount. Companies in the DTC genetic testing space must invest in robust security measures, transparent privacy policies, and clear communication to build and maintain consumer trust. Addressing these concerns is essential for the sustainable growth of the market and fostering a secure environment for individuals to explore their genetic information.

Accuracy and Interpretation of Results

The challenge of accuracy and interpretation of results in the Direct-to-Consumer (DTC) Genetic Testing Market stems from the complexity of genetic data and the evolving nature of scientific knowledge. Variability in testing methodologies can lead to discrepancies, and the intricate nature of genetic information demands precision. Ensuring that consumers receive reliable and meaningful insights requires continuous efforts to enhance testing accuracy and improve result interpretation. Striking a balance between providing comprehensive genetic information and maintaining precision is essential to address this challenge and instill confidence in consumers regarding the reliability of their DTC genetic testing outcomes.

Regulatory and Ethical Considerations

Regulatory and ethical considerations pose significant challenges for the Direct-to-Consumer (DTC) Genetic Testing Market. The dynamic regulatory landscape requires companies to navigate evolving frameworks while ensuring compliance and innovation. Ethical concerns revolve around responsible use of genetic information, potential psychological impacts on consumers, and the need for informed consent. Striking a balance between promoting innovation, protecting consumers, and upholding ethical standards is a delicate challenge. Companies must actively engage in transparent communication, adhere to evolving regulatory requirements, and establish ethical guidelines to address these challenges and foster a trustworthy environment for consumers exploring DTC genetic testing services.

Genetic Counseling and Informed Consent

Genetic counseling and obtaining informed consent present significant challenges for the Direct-to-Consumer (DTC) Genetic Testing Market. The absence of direct, in-person genetic counseling within the DTC model raises concerns regarding consumers' capacity to comprehend intricate genetic information and the potential health implications. Ensuring sufficient support and securing informed consent emerge as critical obstacles, particularly given the nuanced nature of genetic data. Balancing accessibility with the necessity for comprehensive understanding presents a formidable challenge. Addressing this challenge entails developing effective methods for providing genetic counseling remotely, thereby empowering consumers with the knowledge required to make informed decisions about their health based on the results of DTC genetic testing.

Key Market Trends

Expanded Test Offerings and Services

The trend of expanded test offerings and services in the Direct-to-Consumer (DTC) Genetic Testing Market signifies a shift beyond traditional health-related insights. Companies are diversifying their portfolios to include a broader range of genetic tests, such as ancestry testing, trait analysis, and wellness assessments. This expansion provides consumers with a more comprehensive understanding of their genetic makeup, catering to diverse interests and preferences. By offering a spectrum of tests, DTC genetic testing services aim to engage a wider audience and meet the evolving demands of consumers who seek a holistic view of their genetic information, extending beyond medical implications to encompass various aspects of personal identity and well-being.

Telehealth and Remote Counseling

The trend of telehealth and remote counseling is gaining prominence in the Direct-to-Consumer (DTC) Genetic Testing Market, addressing the challenge of genetic counseling accessibility. Companies are leveraging digital platforms to provide consumers with convenient access to genetic counseling services remotely. This ensures that individuals receive guidance and support in interpreting complex genetic test results from the comfort of their homes. The integration of telehealth not only enhances the overall consumer experience but also promotes informed decision-making. By embracing remote counseling, DTC genetic testing services are bridging the gap between consumers and genetic expertise, making genetic information more accessible and understandable.

Segmental Insights

Test Type Insights

Basedon the test type, ancestry and relationship testing emerged as the fastest growing segment in the Global Direct-to-Consumer (DTC) Genetic Testing Market due to its broad consumer appeal and non-medical nature. This category provides insights into one's heritage, family origins, and connections with relatives, appealing to a diverse consumer base interested in exploring their ancestral roots. The allure of genealogy, family history, and discovering genetic relatives greatly fuels the popularity of Ancestry and Relationship Testing. This non-clinical emphasis aligns with the increasing trend of consumers seeking a comprehensive understanding of their genetic makeup beyond health-related aspects, making it a significantly growing and widely embraced segment in the DTC genetic testing industry.

Technology Insights

Single Nucleotide Polymorphism (SNP) chips dominate the Global Direct-to-Consumer (DTC) Genetic Testing Market due to their efficiency in providing comprehensive genetic insights at an affordable cost. These chips analyze variations in single nucleotides across the genome, offering a cost-effective method for identifying genetic markers associated with various traits, ancestry, and health conditions. The widespread use of SNP chips enables large-scale genotyping, facilitating the generation of extensive genetic data for consumers. This dominance is driven by the balance of accuracy, affordability, and the ability to cover a broad spectrum of genetic information, making SNP chips a preferred choice in the DTC genetic testing landscape.

Regional Insights

North America asserts its dominance in the Global Direct-to-Consumer (DTC) Genetic Testing Market owing to factors such as widespread consumer awareness, favorable regulatory environments, and a robust healthcare infrastructure. The region's tech-savvy population and high disposable income significantly contribute to its substantial market share, as consumers increasingly seek personalized genetic insights. The presence of key market players, active promotion of DTC genetic testing services, and a culture of early technology adoption further bolster North America's leadership position. Collaborative efforts between DTC genetic testing companies and research institutions also enhance the region's status as a hub for genetic testing innovations and advancements.

Key Market Players

23andMe, Inc

Ancestry.com, LLC

Color Health, Inc

Helix, Inc.

Counsyl, Inc.

MyHeritage Ltd.

Living DNA Ltd.

Mapmygenome India Limited

Full Genomes Corporation, Inc

Direct Laboratory Services, LLC

Report Scope:

In this report, the Global Direct-To-Consumer (DTC) Genetic Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Direct-To-Consumer (DTC) Genetic Testing Market,By Test Type:

• Ancestry Relationship Testing
• Predictive Testing
• Nutrigenomic Testing
• Carrier Testing
• Skincare Testing
• Others

Direct-To-Consumer (DTC) Genetic Testing Market,By Technology:

• Single Nucleotide Polymorphism (SP) chips
• Targeted Analysis
• Whole Genome Sequencing (WGS)
• Others

Direct-To-Consumer (DTC) Genetic Testing Market,By Sample:

• Saliva
• Urine
• Blood
• Others

Direct-To-Consumer (DTC) Genetic Testing Market,By Distribution Channel:

• Online
• Offline

Direct-To-Consumer (DTC) Genetic Testing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Direct-To-Consumer (DTC) Genetic Testing Market.

Available Customizations:

Global Direct-To-Consumer (DTC) Genetic Testing market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

• 1.1.Market Definition
• 1.2.Scope of the Market
  • 1.2.1.Markets Covered
  • 1.2.2.Years Considered for Study
  • 1.2.3.Key Market Segmentations

2.Research Methodology

• 2.1.Objective of the Study
• 2.2.Baseline Methodology
• 2.3.Key Industry Partners
• 2.4.Major Association and Secondary Sources
• 2.5.Forecasting Methodology
• 2.6.Data Triangulation Validation
• 2.7.Assumptions and Limitations

3.Executive Summary

• 3.1.Overview of the Market
• 3.2.Overview of Key Market Segmentations
• 3.3.Overview of Key Market Players
• 3.4.Overview of Key Regions/Countries
• 3.5.Overview of Market Drivers, Challenges, Trends

4.Global Direct-To-Consumer (DTC) Genetic Testing Market Outlook

• 4.1.Market Size Forecast
  • 4.1.1.By Value
• 4.2.Market Share Forecast
  • 4.2.1.By Test Type (Ancestry Relationship Testing, Predictive Testing, Nutrigenomic Testing, Carrier Testing, Skincare Testing, Others)
  • 4.2.2.By Technology (Single Nucleotide Polymorphism (SP) chips, Targeted Analysis, Whole Genome Sequencing (WGS), Others)
  • 4.2.3.By Sample (Saliva, Urine, Blood, Others)
  • 4.2.4.By Distribution Channel (Online, Offline)
  • 4.2.5.By Region
  • 4.2.6.By Company (2023)
• 4.3.Market Map

5.Asia Pacific Direct-To-Consumer (DTC) Genetic Testing Market Outlook

• 5.1.Market Size Forecast
  • 5.1.1.By Value
• 5.2.Market Share Forecast
  • 5.2.1.By Test Type
  • 5.2.2.By Technology
  • 5.2.3.By Sample
  • 5.2.4.By Distribution Channel
  • 5.2.5.By Country
• 5.3.Asia Pacific: Country Analysis
  • 5.3.1.China Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 5.3.1.1.Market Size Forecast
      • 5.3.1.1.1.By Value
    • 5.3.1.2.Market Share Forecast
      • 5.3.1.2.1.By Test Type
      • 5.3.1.2.2.By Technology
      • 5.3.1.2.3.By Sample
      • 5.3.1.2.4.By Distribution Channel
  • 5.3.2.India Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 5.3.2.1.Market Size Forecast
      • 5.3.2.1.1.By Value
    • 5.3.2.2.Market Share Forecast
      • 5.3.2.2.1.By Test Type
      • 5.3.2.2.2.By Technology
      • 5.3.2.2.3.By Sample
      • 5.3.2.2.4.By Distribution Channel
  • 5.3.3.Australia Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 5.3.3.1.Market Size Forecast
      • 5.3.3.1.1.By Value
    • 5.3.3.2.Market Share Forecast
      • 5.3.3.2.1.By Test Type
      • 5.3.3.2.2.By Technology
      • 5.3.3.2.3.By Sample
      • 5.3.3.2.4.By Distribution Channel
  • 5.3.4.Japan Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 5.3.4.1.Market Size Forecast
      • 5.3.4.1.1.By Value
    • 5.3.4.2.Market Share Forecast
      • 5.3.4.2.1.By Test Type
      • 5.3.4.2.2.By Technology
      • 5.3.4.2.3.By Sample
      • 5.3.4.2.4.By Distribution Channel
  • 5.3.5.South Korea Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 5.3.5.1.Market Size Forecast
      • 5.3.5.1.1.By Value
    • 5.3.5.2.Market Share Forecast
      • 5.3.5.2.1.By Test Type
      • 5.3.5.2.2.By Technology
      • 5.3.5.2.3.By Sample
      • 5.3.5.2.4.By Distribution Channel

6.Europe Direct-To-Consumer (DTC) Genetic Testing Market Outlook

• 6.1.Market Size Forecast
  • 6.1.1.By Value
• 6.2.Market Share Forecast
  • 6.2.1.By Test Type
  • 6.2.2.By Technology
  • 6.2.3.By Sample
  • 6.2.4.By Distribution Channel
  • 6.2.5.By Country
• 6.3.Europe: Country Analysis
  • 6.3.1.France Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 6.3.1.1.Market Size Forecast
      • 6.3.1.1.1.By Value
    • 6.3.1.2.Market Share Forecast
      • 6.3.1.2.1.By Test Type
      • 6.3.1.2.2.By Technology
      • 6.3.1.2.3.By Sample
      • 6.3.1.2.4.By Distribution Channel
  • 6.3.2.Germany Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 6.3.2.1.Market Size Forecast
      • 6.3.2.1.1.By Value
    • 6.3.2.2.Market Share Forecast
      • 6.3.2.2.1.By Test Type
      • 6.3.2.2.2.By Technology
      • 6.3.2.2.3.By Sample
      • 6.3.2.2.4.By Distribution Channel
  • 6.3.3.Spain Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 6.3.3.1.Market Size Forecast
      • 6.3.3.1.1.By Value
    • 6.3.3.2.Market Share Forecast
      • 6.3.3.2.1.By Test Type
      • 6.3.3.2.2.By Technology
      • 6.3.3.2.3.By Sample
      • 6.3.3.2.4.By Distribution Channel
  • 6.3.4.Italy Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 6.3.4.1.Market Size Forecast
      • 6.3.4.1.1.By Value
    • 6.3.4.2.Market Share Forecast
      • 6.3.4.2.1.By Test Type
      • 6.3.4.2.2.By Technology
      • 6.3.4.2.3.By Sample
      • 6.3.4.2.4.By Distribution Channel
  • 6.3.5.United Kingdom Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 6.3.5.1.Market Size Forecast
      • 6.3.5.1.1.By Value
    • 6.3.5.2.Market Share Forecast
      • 6.3.5.2.1.By Test Type
      • 6.3.5.2.2.By Technology
      • 6.3.5.2.3.By Sample
      • 6.3.5.2.4.By Distribution Channel

7.North America Direct-To-Consumer (DTC) Genetic Testing Market Outlook

• 7.1.Market Size Forecast
  • 7.1.1.By Value
• 7.2.Market Share Forecast
  • 7.2.1.By Test Type
  • 7.2.2.By Technology
  • 7.2.3.By Sample
  • 7.2.4.By Distribution Channel
  • 7.2.5.By Country
• 7.3.North America: Country Analysis
  • 7.3.1.United States Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 7.3.1.1.Market Size Forecast
      • 7.3.1.1.1.By Value
    • 7.3.1.2.Market Share Forecast
      • 7.3.1.2.1.By Test Type
      • 7.3.1.2.2.By Technology
      • 7.3.1.2.3.By Sample
      • 7.3.1.2.4.By Distribution Channel
  • 7.3.2.Mexico Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 7.3.2.1.Market Size Forecast
      • 7.3.2.1.1.By Value
    • 7.3.2.2.Market Share Forecast
      • 7.3.2.2.1.By Test Type
      • 7.3.2.2.2.By Technology
      • 7.3.2.2.3.By Sample
      • 7.3.2.2.4.By Distribution Channel
  • 7.3.3.Canada Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 7.3.3.1.Market Size Forecast
      • 7.3.3.1.1.By Value
    • 7.3.3.2.Market Share Forecast
      • 7.3.3.2.1.By Test Type
      • 7.3.3.2.2.By Technology
      • 7.3.3.2.3.By Sample
      • 7.3.3.2.4.By Distribution Channel

8.South America Direct-To-Consumer (DTC) Genetic Testing Market Outlook

• 8.1.Market Size Forecast
  • 8.1.1.By Value
• 8.2.Market Share Forecast
  • 8.2.1.By Test Type
  • 8.2.2.By Technology
  • 8.2.3.By Sample
  • 8.2.4.By Distribution Channel
  • 8.2.5.By Country
• 8.3.South America: Country Analysis
  • 8.3.1.Brazil Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 8.3.1.1.Market Size Forecast
      • 8.3.1.1.1.By Value
    • 8.3.1.2.Market Share Forecast
      • 8.3.1.2.1.By Test Type
      • 8.3.1.2.2.By Technology
      • 8.3.1.2.3.By Sample
      • 8.3.1.2.4.By Distribution Channel
  • 8.3.2.Argentina Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 8.3.2.1.Market Size Forecast
      • 8.3.2.1.1.By Value
    • 8.3.2.2.Market Share Forecast
      • 8.3.2.2.1.By Test Type
      • 8.3.2.2.2.By Technology
      • 8.3.2.2.3.By Sample
      • 8.3.2.2.4.By Distribution Channel
  • 8.3.3.Colombia Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 8.3.3.1.Market Size Forecast
      • 8.3.3.1.1.By Value
    • 8.3.3.2.Market Share Forecast
      • 8.3.3.2.1.By Test Type
      • 8.3.3.2.2.By Technology
      • 8.3.3.2.3.By Sample
      • 8.3.3.2.4.By Distribution Channel

9.Middle East and Africa Direct-To-Consumer (DTC) Genetic Testing Market Outlook

• 9.1.Market Size Forecast
  • 9.1.1.By Value
• 9.2.Market Share Forecast
  • 9.2.1.By Test Type
  • 9.2.2.By Technology
  • 9.2.3.By Sample
  • 9.2.4.By Distribution Channel
  • 9.2.5.By Country
• 9.3.MEA: Country Analysis
  • 9.3.1.South Africa Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 9.3.1.1.Market Size Forecast
      • 9.3.1.1.1.By Value
    • 9.3.1.2.Market Share Forecast
      • 9.3.1.2.1.By Test Type
      • 9.3.1.2.2.By Technology
      • 9.3.1.2.3.By Sample
      • 9.3.1.2.4.By Distribution Channel
  • 9.3.2.Saudi Arabia Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 9.3.2.1.Market Size Forecast
      • 9.3.2.1.1.By Value
    • 9.3.2.2.Market Share Forecast
      • 9.3.2.2.1.By Test Type
      • 9.3.2.2.2.By Technology
      • 9.3.2.2.3.By Sample
      • 9.3.2.2.4.By Distribution Channel
  • 9.3.3.UAE Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 9.3.3.1.Market Size Forecast
      • 9.3.3.1.1.By Value
    • 9.3.3.2.Market Share Forecast
      • 9.3.3.2.1.By Test Type
      • 9.3.3.2.2.By Technology
      • 9.3.3.2.3.By Sample
      • 9.3.3.2.4.By Distribution Channel

10.Market Dynamics

• 10.1.Drivers
• 10.2.Challenges

11.Market Trends Developments

• 11.1.Recent Developments
• 11.2.Product Launches
• 11.3.Mergers Acquisitions

12.Global Direct-To-Consumer (DTC) Genetic Testing Market: SWOT Analysis

13.Porter's Five Forces Analysis

• 13.1.Competition in the Industry
• 13.2.Potential of New Entrants
• 13.3.Power of Suppliers
• 13.4.Power of Customers
• 13.5.Threat of Substitute Product

14.Competitive Landscape

• 14.1.23andMe, Inc
  • 14.1.1.Business Overview
  • 14.1.2.Company Snapshot
  • 14.1.3.Products Services
  • 14.1.4.Financials (As Reported)
  • 14.1.5.Recent Developments
• 14.2.Ancestry.com, LLC
• 14.3.Color Health, Inc
• 14.4.Helix, Inc.
• 14.5.Counsyl, Inc.
• 14.6.MyHeritage Ltd.
• 14.7.Living DNA Ltd.
• 14.8.Mapmygenome India Limited
• 14.9.Full Genomes Corporation, Inc
• 14.10.Direct Laboratory Services, LLC

15.Strategic Recommendations

16.About Us Disclaimer